BLOG

Thursday, July 22, 2021

Evidence of sustained benefits of pimavanserin for dementia-related psychosis

Researchers have published evidence of the sustained benefits of an investigational antipsychotic treatment for people with dementia-related psychosis.

from Top Health News -- ScienceDaily https://ift.tt/3izXsHf
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...